CAS 147782-19-2
:(1R,2R)-3-[(S)-Aminocarboxymethyl]-1,2-cyclopropanedicarboxylic acid
Description:
(1R,2R)-3-[(S)-Aminocarboxymethyl]-1,2-cyclopropanedicarboxylic acid, with CAS number 147782-19-2, is a chiral compound characterized by its unique cyclopropane structure, which features two carboxylic acid functional groups and an amino acid side chain. This compound is notable for its potential applications in pharmaceuticals and biochemistry, particularly in the synthesis of peptide-based drugs or as a building block in organic synthesis. The presence of both carboxylic acid and amino groups indicates that it can participate in various chemical reactions, including peptide bond formation. Its stereochemistry, denoted by the (1R,2R) and (S) configurations, suggests that it may exhibit specific biological activities or interactions, making it of interest in medicinal chemistry. Additionally, the compound's solubility and reactivity can be influenced by its functional groups, which may affect its behavior in biological systems. Overall, this compound represents a valuable entity in the study of chiral molecules and their applications in drug development.
Formula:C7H9NO6
InChI:InChI=1S/C7H9NO6/c8-4(7(13)14)1-2(5(9)10)3(1)6(11)12/h1-4H,8H2,(H,9,10)(H,11,12)(H,13,14)/t2-,3-,4+/m1/s1
InChI key:InChIKey=MATPZHBYOVDBLI-JJYYJPOSSA-N
SMILES:[C@H](C(O)=O)(N)[C@]1([C@@H](C(O)=O)[C@@H]1C(O)=O)[H]
Synonyms:- (1R)-3-[(S)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid
- (1R,2R)-3-[(S)-Aminocarboxymethyl]-1,2-cyclopropanedicarboxylic acid
- (2S,2'R,3'R)-2-(2',3'-Dicarboxycyclopropyl)Glycine
- 1,2-Cyclopropanedicarboxylic acid, 3-(aminocarboxymethyl)-, [1R-[1α,2β,3α(S*)]]-
- 1,2-Cyclopropanedicarboxylic acid, 3-[(S)-aminocarboxymethyl]-, (1R,2R)-
- 2-(2,3-Dicarboxycyclopropyl)Glycine
- 3-[Amino(Carboxy)Methyl]Cyclopropane-1,2-Dicarboxylic Acid
- DCG-IV
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
DCG IV
CAS:<p>DCG IV is a sophisticated fourth-generation tyrosine kinase inhibitor, which is synthesized through advanced medicinal chemistry techniques. Its mode of action involves the selective targeting and inhibition of specific tyrosine kinases that are aberrantly active in certain malignancies. By binding to the ATP-binding sites of these kinases, DCG IV effectively disrupts the signaling pathways that are crucial for cancer cell proliferation and survival.</p>Formula:C7H9NO6Purity:Min. 95%Molecular weight:203.15 g/molDCG-IV
CAS:<p>DCG-IV: Class II mGluR agonist; anticonvulsant; neuroprotective; EC50: mGlu2R-0.35μM, mGlu3R-0.09μM; antagonizes Group I/III mGluRs.</p>Formula:C7H9NO6Purity:98%Color and Shape:SolidMolecular weight:203.15



